OZEMPIC
- Product NDC
- 0169-1715
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oral semaglutide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Application
- NDA213051
- Marketing category
- NDA
- Substance
- SEMAGLUTIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 0169-1715-30 | 30 TABLET in 1 BOTTLE, PLASTIC (0169-1715-30) | 2026-04-27 | | No | Historical |
| 0169-1715-90 | 30 TABLET in 1 BOTTLE, PLASTIC (0169-1715-90) | 2026-04-27 | | Yes | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| OZEMPIC | Novo Nordisk Pharmaceutical Industries, LP | 2026-01-30 | HUMAN PRESCRIPTION DRUG LABEL | 13 |
| RYBELSUS | Novo Nordisk | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL | 10 |